NM 001 - NuMedii
Alternative Names: NM-001 - NuMediiLatest Information Update: 28 Feb 2024
At a glance
- Originator NuMedii; Undisclosed
- Developer NuMedii; Undisclosed Company
- Class Anti-inflammatories; Antiulcers
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Ulcerative colitis
Most Recent Events
- 28 Feb 2024 No recent reports of development identified for research development in Ulcerative-colitis in USA
- 15 Jan 2020 Early research in Ulcerative colitis in USA